Concizumab Antibody
Concizumab is an IgG4 monoclonal antibody targeting the KPI2 domain of TFPI, inhibiting its interaction with FXa to enhance thrombin generation. It is applied in hemophilia research, with studies demonstrating its prophylactic and therapeutic potential in both in vitro coagulation assays and in vivo models.
Product Specifications
Product Name Alternative
NN 7415, NN7415, NN-7415, mAb 2021, Concizumab
Target
Factor Xa, Others
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Metabolism Research
Concentration
6.34 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
145.76 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
